170491-62-0

Basic information

• Product Name: 1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER
• Synonyms: 1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER;tert-Butyl 2-(2-oxoethyl)pyrrolidine-1-carboxylate;1-Boc-2-(2-oxoethyl)pyrrolidine
• CAS NO: 170491-62-0
• Molecular Formula: C₁₁H₁₉NO₃
• Molecular Weight: 213.275
• Mol File: 170491-62-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER(170491-62-0)
• EPA Substance Registry System: 1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER(170491-62-0)

Safety Data

• Hazardous Substances Data: 170491-62-0(Hazardous Substances Data)

Usage

General Description

1-Pyrrolidinecarboxylic acid, 2-(2-oxoethyl)-, 1,1-dimethylethyl ester is a chemical compound with the molecular formula C13H23NO3. It is a derivative of pyrrolidinecarboxylic acid, a cyclic amino acid commonly found in various biological systems. The 2-(2-oxoethyl) group and the 1,1-dimethylethyl ester side chain give this compound unique properties, making it useful in pharmaceutical and chemical research. Its precise applications are not well documented in the literature, but it may have potential as a building block in organic synthesis or as a precursor to novel pharmaceutical compounds. As with all chemicals, proper handling and safety precautions should be observed when working with this compound.

Upstream product

• 176324-60-0 2-(R)-Vinyl-pyrrolidine-1-carboxylic Acid Tert-Butyl Ester 
• 144688-69-7 tert-butyl 2-methoxypyrrolidine-1-carboxylate 
• 109-92-2 ethyl vinyl ether 
• 443797-18-0 tert-butyl 2-(2-(methoxy(methyl)amino)-2-oxoethyl)pyrrolidine-1-carboxylate 
• 220312-34-5 2-(2-hydroxyethyl)pyrrolidine-1-carboxylic acid tert-butyl ester 
• 15761-39-4 N-tert-butoxycarbonyl-proline 
• 813433-68-0 2-methoxycarbonylmethylpyrrolidine-1-carboxylic acid tert-butyl ester 
• 194154-91-1 (+/-)-1-(tert-Butoxycarbonyl)pyrrolidine-2-acetic acid 

Downstream Products

• 1393836-38-8 1,1-diethyl-2-[2-((indan-2-yl)(phenyl)amino)ethyl]pyrrolidinium iodide 
• 1393836-90-2 2-[2-(((indan-2-yl)phenyl)amino)ethyl]pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1393837-06-3 2-[2-(((indan-2-yl)phenyl)amino)ethyl]pyrrolidine 

Relevant articles and documents

NOVEL HISTONE METHYLTRANSFERASE INHIBITORS

The present invention relates to novel compounds of formula (I) as defined herein. The compounds are inhibitors of histone methyltransferases of the seven-beta-strand family, in particular of KMT9.

NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME

Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein each symbol is as defined in the SPECIFICATION.

USE OF AMINOINDANE COMPOUNDS IN TREATING OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS

The present application provides methods of using the aminoindane compounds of formula (I) or (II) in treating an overactive bladder or interstitial cystitis by administering one or more of the compounds to a patient.

Aminoindane Compounds and Use Thereof in Treating Pain

The present application provides novel aminoindane compounds and methods for preparing and using these compounds. These compounds are useful in treating pain and/or itch in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) or (II) and a TRPV 1 receptor activator. In one embodiment, the TRPV 1 receptor activator is lidocaine.

ANTIBACTERIAL FLUOROQUINOLONE ANALOGS

Compounds having antibacterial activity are disclosed. The compounds have one of the following structures (I) or (II): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, J, D, E, G, W, R1, R2/su

Microwave-assisted synthesis of novel (5-nitropyridin-2-yl)alkyl and (5-nitropyridin-3-yl)alkyl carbamates

A straightforward approach to novel (5-nitropyridin-2-yl)alkyl and (5-nitropyridin-3-yl)alkyl carbamate building blocks is presented in this study. Their construction is achieved by condensation of N-carbamate a- and β-amino carbonyl derivatives with l-methyl-3,5-dinitro-2-pyridone 1 under microwave irradiation. Judiciously chosen modifications in the nature of the parent carbonyl starting material has influenced the regiochemical outcome of the reaction and allowed an efficient access to novel nitrogen-containing scaffolds. Compounds sharing morphological similarities have been gathered in three libraries differing from each other in a single structural parameter.

Addition of carbon nucleophiles to cyclic N-acyliminium ions in SDS/water

The acid-catalyzed addition of 1,3-dicarbonyl compounds and activated olefins (silyl enol ethers and ethyl vinyl ether) to N-Boc-2-methoxypyrrolidine (1a) and N-Boc-2-methoxypiperidine (1b) in SDS/water medium is described. Good yields of the correspondin

A synthesis of (±)-ipalbidine using sulfur-controlled 6-exo selective radical cyclization of α-phenylthio amide

A synthesis of (±)-ipalbidine (1) has been achieved using Bu3SnH- mediated 6-exo selective radical cyclization of 2-[3-(phenylthio)prop-2- enyl]-N-[α(p-methoxyphenyl)-α-(phenylthio)acetyl]pyrrolidine (15) as a key step.